OncoHost
Company Details
Status: Private
Employees: 11-50
Location:
Binyamina, Israel
Type:
sample
sample
Technology:
sample
About: OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes.
OncoHost’s proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. The PROphet® NSCLC test provides clear clinical utility by offering physicians crucial guidance on the optimal first-line immunotherapy treatment plan for each individual patient, with a significant effect on overall survival.
Led by an experienced team of entrepreneurs and industry experts and supported by a large-scale prospective clinical trial with over 40 sites and 1,700 patients recruited worldwide, OncoHost is well-positioned to lead precision diagnostics and biomarker development to the next stage.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
OncoHost | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.